It's been nearly nine years since we first sparred over stocks in our daring Dueling Fools feature. Back in 1996, it was a pretty bold move in the laid-back space of financial journalism. In an investing world where the talking heads were -- and still are -- more like nodding heads hurling softball questions, Dueling Fools offered strong, divergent perspectives on the same stock.
Now we're bringing Dueling Fools back to life. A week from today, you will find a pair of our finest writer-analysts offering the bullish and bearish views on next-generation weaponry specialist Taser Systems
The fun won't stop there, though. We have some other exciting clashes in the works to brighten up the summer doldrums in the investment world:
(NYSE:MRK)was once the blue-chip star in big pharma but has since fallen on hard times. Is now the time to buy?
(NYSE:HD)has also been humbled lately. Is it time to don the orange apron?
- Feeling chicken over Buffalo Wild Wings
- Is your biotech itch ready to scratch Protein Design Labs
There is no perfect stock out there, no matter what that guy told you at last week's cocktail party.
And by donning our bull glasses and bear goggles alike, we hope that you'll walk away with a greater appreciation of the analytical process.
In the weeks to come, we will also feature two of the most discussed stocks in all of Fooldom: Krispy Kreme
You won't want to miss the bouts. Do stay close come Thursdays this summer. Just not too close -- sharp words can hurt.
Longtime Fool contributor Rick Munarriz helped turn Dueling Fools into a reality back in the happy AOL days of 1996. He does not own shares in any of the companies mentioned in this story. The Fool has a disclosure policy. He is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early.
More from The Motley Fool
Cinemark Declares War on MoviePass With $8.99 Subscription
The new Movie Club offering is more competitive than you might think ...
5 Big Banks Currently Testing Ripple's Blockchain Technology
The possibility of instantly settling cross-border transactions has these five banks very excited.
The 3 Best Biotech Stocks of 2017
What did it take to rank among the top three biotech stocks this year? At least a 440% gain.